marketcaparena
Search

    VRDN

    Viridian Therapeutics, Inc.\DE

    Company overview

    Market capitalization
    $2.33B
    Employees
    252
    Latest publication
    2026-09-29
    About Viridian Therapeutics, Inc.\DE

    Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered, and Elegrobart, a low-volume, infrequently dosed subcutaneous IGF-1R. The company also develops an anti-thyroid-stimulating hormone receptor (TSHR) candidate for the treatment of Graves' disease and TED. Its portfolio of engineered inhibitors of the neonatal Fc receptor (FcFn) includes VRDN-006, a highly selective Fc fragment, and VRDN-008, a half-life extended bispecific FcRn inhibitor comprising an GC fragment and an albumin-binding domain designed to prolong IGG suppression. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was incorporated in 2010 and is headquartered in Waltham, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue284,000USD141,000USD132,000USD70,570,000USD75,000USD72,000USD72,000USD86,000USD
    Selling General Administrative54,975,000USD38,679,000USD33,674,000USD24,322,000USD20,216,000USD17,103,000USD15,584,000USD14,408,000USD
    Total Operating Expenses126,552,000USD116,189,000USD122,561,000USD110,583,000USD106,842,000USD93,938,000USD87,544,000USD83,566,000USD
    Operating Income-126,268,000USD-116,169,000USD-122,749,000USD-40,013,000USD-106,767,000USD-93,866,000USD-87,472,000USD-83,480,000USD
    Total Other Income Expense Net-851,000USD11,268,000USD2,394,000USD5,414,000USD6,032,000USD6,954,000USD7,747,000USD6,791,000USD
    Interest Income8,490,000USD7,872,000USD7,792,000USD5,521,000USD6,546,000USD7,540,000USD8,605,000USD7,795,000USD
    Interest Expense8,307,000USD3,462,000USD6,608,000USD560,000USD514,000USD586,000USD858,000USD1,004,000USD
    Net Income-127,119,000USD-104,901,000USD-120,355,000USD-34,599,000USD-100,735,000USD-86,912,000USD-79,725,000USD-76,689,000USD
    Cost Of Revenue—121,000USD320,000USD———123,000USD—
    Gross Profit—20,000USD-188,000USD70,570,000USD75,000USD72,000USD72,000USD86,000USD
    Research Development—77,631,000USD89,207,000USD86,261,000USD86,626,000USD76,835,000USD71,960,000USD69,158,000USD
    Net Interest Income—4,410,000USD4,510,000USD4,961,000USD6,032,000USD6,954,000USD7,747,000USD6,791,000USD
    Income Before Tax—-104,901,000USD-120,355,000USD-34,599,000USD-100,735,000USD-86,912,000USD-79,725,000USD-76,689,000USD
    Net Income From Continuing Ops—-104,901,000USD-120,355,000USD-34,599,000USD-100,735,000USD-86,912,000USD-79,725,000USD-76,689,000USD
    Ebit—-101,439,000USD-113,747,000USD-34,039,000USD-100,221,000USD-86,326,000USD-78,867,000USD-75,685,000USD
    Ebitda—-101,318,000USD-114,087,000USD-33,929,000USD-100,108,000USD-86,209,000USD-78,744,000USD-75,555,000USD
    Depreciation And Amortization—121,000USD-340,000USD110,000USD113,000USD117,000USD123,000USD130,000USD
    Reconciled Depreciation—121,000USD120,000USD110,000USD113,000USD117,000USD123,000USD130,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20212021-12-31 · USDFY 20192019-12-31 · USDFY 20172017-12-31 · USD
    Total Revenue70,849,000USD2,963,000USD4,461,000USD4,003,000USD
    Cost Of Revenue1,160,000USD620,000USD32,794,000USD19,623,000USD
    Gross Profit70,849,000USD2,963,000USD4,461,000USD-15,620,000USD
    Research Development338,929,000USD56,886,000USD34,794,000USD19,623,000USD
    Selling General Administrative95,315,000USD25,805,000USD11,646,000USD10,912,000USD
    Total Operating Expenses434,244,000USD82,691,000USD46,440,000USD30,535,000USD
    Operating Income-363,395,000USD-79,728,000USD-41,979,000USD-26,532,000USD
    Interest Income27,399,000USD318,000USD941,000USD403,000USD
    Interest Expense4,948,000USD3,000USD835,000USD383,000USD
    Net Interest Income22,451,000USD315,000USD106,000USD20,000USD
    Income Before Tax-342,601,000USD-79,413,000USD-41,873,000USD-26,512,000USD
    Net Income-342,601,000USD-79,413,000USD-41,873,000USD-26,512,000USD
    Net Income From Continuing Ops-342,601,000USD-79,562,000USD-41,873,000USD-26,512,000USD
    Ebit-337,653,000USD-79,410,000USD-41,038,000USD-26,129,000USD
    Ebitda-337,193,000USD-79,290,000USD-40,750,000USD-25,821,000USD
    Depreciation And Amortization460,000USD120,000USD288,000USD308,000USD
    Reconciled Depreciation460,000USD120,000USD288,000USD308,000USD
    Total Other Income Expense Net20,794,000USD315,000USD106,000USD20,000USD
    Income Tax Expense—3,000USD547,000USD95,000USD
    Non Operating Income Net Other—169,000USD——
    Net Income Applicable To Common Shares—-79,413,000USD-41,873,000USD-26,517,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,097,233,000USD789,017,000USD899,418,000USD577,138,000USD582,324,000USD660,981,000USD742,403,000USD771,900,000USD
    Cash And Equivalents164,986,000USD———————
    Total Current Assets1,081,270,000USD784,744,000USD894,233,000USD571,913,000USD578,750,000USD657,238,000USD738,461,000USD767,357,000USD
    Other Current Assets24,740,000USD22,563,000USD19,581,000USD11,012,000USD15,394,000USD20,605,000USD20,877,000USD14,103,000USD
    Other Non Current Assets1,113,000USD———————
    Total Liabilities435,136,000USD———————
    Total Current Liabilities63,794,000USD51,805,000USD70,696,000USD50,696,000USD52,585,000USD33,727,000USD47,874,000USD41,364,000USD
    Other Current Liabilities55,142,000USD———————
    Other Non Current Liabilities1,851,000USD———————
    Total Stockholder Equity662,097,000USD636,008,000USD722,167,000USD502,970,000USD515,169,000USD604,473,000USD671,639,000USD707,496,000USD
    Total Equity Including Noncontrolling Interest662,097,000USD———————
    Property Plant Equipment Net4,850,000USD3,385,000USD3,649,000USD3,707,000USD3,068,000USD3,254,000USD3,441,000USD3,690,000USD
    Accounts Payable8,652,000USD13,313,000USD8,683,000USD10,063,000USD8,518,000USD3,886,000USD2,143,000USD6,338,000USD
    Common Stock1,132,000USD1,024,999USD1,018,000USD822,000USD817,000USD816,000USD810,000USD792,000USD
    Retained Earnings-1,570,478,000USD-1,443,359,000USD-1,338,458,000USD-1,218,103,000USD-1,183,504,000USD-1,082,769,000USD-995,857,000USD-916,132,000USD
    Accumulated Other Comprehensive Income-1,153,000USD-558,000USD447,000USD363,000USD69,000USD245,000USD-10,000USD931,999USD
    Total Liab—153,009,000USD177,251,000USD74,168,000USD67,155,000USD56,508,000USD70,764,000USD64,404,000USD
    Other Current Liab—37,480,000USD60,893,000USD39,531,000USD34,791,000USD29,017,000USD44,930,000USD34,149,000USD
    Capital Stock—133,081,000USD133,074,000USD189,707,000USD189,702,000USD189,701,000USD189,695,000USD189,677,000USD
    Cash—176,346,000USD212,382,000USD169,647,000USD117,324,000USD116,215,000USD99,594,000USD200,317,000USD
    Cash And Short Term Investments—762,181,000USD874,652,000USD490,901,000USD563,356,000USD636,633,000USD717,584,000USD753,240,000USD
    Current Deferred Revenue—274,000USD367,000USD372,000USD288,000USD288,000USD288,000USD288,000USD
    Net Debt—-125,172,000USD-161,689,000USD-145,827,000USD-95,983,000USD-94,994,000USD-78,499,000USD-179,205,000USD
    Short Term Debt—738,000USD753,000USD730,000USD8,988,000USD536,000USD513,000USD589,000USD
    Short Long Term Debt Total—51,174,000USD50,693,000USD23,820,000USD21,341,000USD21,221,000USD21,095,000USD21,112,000USD
    Long Term Debt—50,436,000USD49,940,000USD20,890,000USD12,353,000USD20,685,000USD20,582,000USD20,523,000USD
    Short Term Investments—585,835,000USD662,270,000USD321,254,000USD446,032,000USD520,418,000USD617,990,000USD552,923,000USD
    Property Plant Equipment Gross—3,385,000USD4,865,000USD3,707,000USD3,068,000USD3,254,000USD4,707,000USD3,690,000USD
    Common Stock Shares Outstanding—102,211,657shares84,803,355shares81,784,499shares81,593,463shares81,344,134shares80,052,123shares66,420,063shares
    Non Current Assets Total—4,273,000USD5,185,000USD5,225,000USD3,574,000USD3,743,000USD3,942,000USD4,543,000USD
    Non Current Liabilities Total—101,204,000USD106,555,000USD23,472,000USD14,570,000USD22,781,000USD22,890,000USD23,040,000USD
    Non Current Liabilities Other—2,176,000USD2,341,000USD2,582,000USD2,077,000USD1,884,000USD2,024,000USD2,161,000USD
    Non Currrent Assets Other—888,000USD1,536,000USD1,518,000USD506,000USD489,000USD501,000USD853,000USD
    Net Working Capital—732,939,000USD823,537,000USD521,217,000USD526,165,000USD623,511,000USD690,587,000USD725,993,000USD
    Unclassified Non Current Liabilities—48,592,000USD54,274,000USD—————
    Unclassified Equity—1,945,819,001USD1,926,086,000USD1,530,181,000USD1,508,085,000USD1,496,480,000USD1,477,001,000USD1,432,227,001USD
    Net Receivables———70,000,000USD———14,000USD
    Short Long Term Debt————8,435,000USD———
    Unclassified Current Liabilities————-8,435,000USD———
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets899,418,000USD742,403,000USD490,424,000USD435,091,000USD203,709,000USD131,255,000USD30,262,000USD66,147,000USD
    Other Current Assets19,581,000USD20,877,000USD9,006,000USD6,521,000USD2,747,000USD1,972,000USD2,786,000USD5,230,000USD
    Total Liab177,251,000USD70,764,000USD48,402,000USD40,027,000USD15,993,000USD11,218,000USD14,508,000USD14,803,000USD
    Total Stockholder Equity722,167,000USD671,639,000USD442,022,000USD395,064,000USD187,716,000USD120,037,000USD15,754,000USD51,344,000USD
    Other Current Liab60,893,000USD44,930,000USD23,265,000USD18,214,000USD10,498,000USD9,248,000USD5,108,000USD3,868,000USD
    Common Stock1,018,000USD810,000USD540,000USD414,000USD239,000USD42,000USD23,000USD308,000USD
    Capital Stock133,074,000USD189,695,000USD207,056,000USD142,561,000USD134,072,000USD180,843,000USD349,000USD308,000USD
    Retained Earnings-1,338,458,000USD-995,857,000USD-725,908,000USD-488,174,000USD-358,300,000USD-278,887,000USD-168,169,000USD-126,296,000USD
    Cash212,382,000USD99,594,000USD102,827,000USD155,579,000USD42,299,000USD45,897,000USD24,846,000USD32,606,000USD
    Cash And Short Term Investments874,652,000USD717,584,000USD477,370,000USD424,550,000USD196,965,000USD127,639,000USD26,845,000USD62,481,000USD
    Total Current Assets894,233,000USD738,461,000USD486,478,000USD424,550,000USD200,163,000USD129,611,000USD29,739,000USD65,370,000USD
    Total Current Liabilities70,696,000USD47,874,000USD26,635,000USD33,349,000USD13,636,000USD10,674,000USD10,180,000USD6,733,000USD
    Current Deferred Revenue367,000USD288,000USD288,000USD288,000USD289,000USD301,000USD5,008,000USD3,786,000USD
    Net Debt-161,689,000USD-78,499,000USD-81,779,000USD-150,321,000USD-41,259,000USD-45,442,000USD-16,542,000USD-22,308,000USD
    Short Term Debt753,000USD513,000USD843,000USD613,000USD520,000USD455,000USD3,976,000USD2,294,000USD
    Short Long Term Debt Total50,693,000USD21,095,000USD21,048,000USD5,258,000USD1,040,000USD455,000USD8,304,000USD10,298,000USD
    Long Term Debt49,940,000USD20,582,000USD20,205,000USD4,645,000USD——4,328,000USD8,004,000USD
    Short Term Investments662,270,000USD617,990,000USD374,543,000USD268,971,000USD154,666,000USD81,742,000USD1,999,000USD29,875,000USD
    Accounts Payable8,683,000USD2,143,000USD2,239,000USD14,234,000USD2,329,000USD670,000USD1,096,000USD571,000USD
    Property Plant Equipment Net3,649,000USD3,441,000USD3,342,000USD2,936,000USD2,055,000USD787,000USD523,000USD727,000USD
    Property Plant Equipment Gross4,865,000USD4,707,000USD4,391,000USD4,940,000USD3,831,000USD787,000USD523,000USD727,000USD
    Accumulated Other Comprehensive Income447,000USD-10,000USD338,000USD-390,000USD-157,000USD-8,000USD-3,348,000USD-3,000USD
    Common Stock Shares Outstanding84,803,355shares67,886,000shares44,755,475shares32,087,293shares11,918,712shares3,557,065shares2,089,094shares1,973,365shares
    Non Current Assets Total5,185,000USD3,942,000USD3,946,000USD10,541,000USD3,546,000USD1,644,000USD523,000USD777,000USD
    Non Current Liabilities Total106,555,000USD22,890,000USD21,767,000USD6,678,000USD2,357,000USD544,000USD4,328,000USD8,070,000USD
    Non Current Liabilities Other2,341,000USD2,024,000USD989,000USD1,172,000USD2,357,000USD544,000USD—66,000USD
    Non Currrent Assets Other1,536,000USD501,000USD604,000USD7,605,000USD1,491,000USD857,000USD-523,000USD50,000USD
    Net Working Capital823,537,000USD690,587,000USD459,843,000USD397,824,000USD186,527,000USD118,937,000USD19,559,000USD58,637,000USD
    Unclassified Non Current Liabilities54,274,000USD———-2,357,000USD———
    Unclassified Equity1,926,086,000USD1,477,001,000USD959,996,000USD740,653,000USD411,862,000USD218,047,000USD186,899,000USD177,027,000USD
    Net Receivables——102,000USD102,000USD451,000USD—108,000USD24,000USD
    Other Liab———933,000USD2,357,000USD501,000USD—66,000USD
    Other Assets———982,000USD318,131,000USD1,335,000USD—50,000USD
    Inventory———-6,623,000USD————
    Net Tangible Assets———252,917,000USD53,883,000USD-60,764,000USD15,754,000USD51,344,000USD
    Unclassified Current Assets———-6,623,000USD———-2,365,000USD
    Unclassified Non Current Assets————-318,131,000USD-1,335,000USD——
    Short Long Term Debt——————3,976,000USD2,294,000USD
    Unclassified Current Liabilities——————-8,984,000USD-6,080,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-104,901,000USD-120,355,000USD-34,599,000USD-100,735,000USD-86,912,000USD-79,725,000USD-76,689,000USD-64,993,000USD
    Depreciation121,000USD-868,000USD110,000USD113,000USD117,000USD123,000USD-12,617,000USD142,000USD
    Stock Based Compensation13,390,000USD11,989,000USD11,250,000USD10,844,000USD10,220,000USD8,975,000USD8,720,000USD11,767,000USD
    Other Non Cash Items-6,874,000USD4,131,000USD-1,044,000USD-1,460,000USD-2,223,000USD-3,165,000USD19,050,000USD-4,102,000USD
    Change In Working Capital-21,390,000USD81,349,000USD-60,328,000USD15,865,000USD-13,855,000USD460,000USD-6,170,000USD11,128,000USD
    Total Cash From Operating Activities-119,654,000USD-23,754,000USD-84,611,000USD-75,373,000USD-92,653,000USD-73,332,000USD-67,706,000USD-46,058,000USD
    Capital Expenditures-23,000USD-240,000USD-127,000USD-42,000USD-86,000USD-114,000USD-293,000USD-104,000USD
    Free Cash Flow-119,677,000USD-23,994,000USD-84,738,000USD-75,415,000USD-92,739,000USD-73,446,000USD-67,999,000USD-46,162,000USD
    Investments77,284,000USD-339,180,000USD126,077,000USD75,718,000USD100,062,000USD-62,915,000USD-84,667,000USD61,976,000USD
    Total Cashflows From Investing Activities77,261,000USD-339,420,000USD126,077,000USD75,718,000USD100,062,000USD-62,915,000USD-84,667,000USD61,976,000USD
    Total Cash From Financing Activities6,357,000USD405,909,000USD10,857,000USD764,000USD9,212,000USD35,524,000USD245,023,000USD108,000USD
    Issuance Of Capital Stock0USD337,293,000USD9,960,000USD1,000USD4,943,000USD33,646,000USD258,750,000USD0USD
    Change In Cash-36,036,000USD42,735,000USD52,323,000USD1,109,000USD16,621,000USD-100,723,000USD92,650,000USD16,026,000USD
    Begin Period Cash Flow212,382,000USD169,647,000USD117,324,000USD116,215,000USD99,594,000USD200,317,000USD107,667,000USD91,641,000USD
    End Period Cash Flow176,346,000USD212,382,000USD169,647,000USD117,324,000USD116,215,000USD99,594,000USD200,317,000USD107,667,000USD
    Other Cashflows From Financing Activities6,357,000USD49,541,000USD897,000USD763,000USD4,269,000USD1,878,000USD11,274,000USD108,000USD
    Sale Purchase Of Stock—-1,123,000USD1,120,000USD561,000USD——317,000USD—
    Unclassified Financing Cash Flow—357,491,000USD8,840,000USD———233,432,000USD—
    Change To Account Receivables——-70,000,000USD——14,000USD-102,000USD102,000USD
    Net Borrowings—————0USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-342,601,000USD-269,949,000USD-237,734,000USD-129,874,000USD-79,413,000USD-110,715,000USD-41,873,000USD-32,703,000USD
    Depreciation-6,758,000USD540,000USD522,000USD255,000USD120,000USD239,000USD288,000USD281,000USD
    Stock Based Compensation44,303,000USD42,150,000USD67,172,000USD19,765,000USD14,465,000USD3,645,000USD3,970,000USD3,679,000USD
    Other Non Cash Items5,634,000USD-14,658,000USD-4,705,000USD54,000USD8,523,000USD72,569,000USD340,000USD376,000USD
    Change In Working Capital23,031,000USD9,598,000USD-9,425,000USD15,962,000USD1,724,000USD4,427,000USD1,651,000USD1,939,000USD
    Total Cash From Operating Activities-276,391,000USD-232,319,000USD-184,170,000USD-93,838,000USD-54,581,000USD-29,779,000USD-36,056,000USD-26,844,000USD
    Capital Expenditures-495,000USD-511,000USD-898,000USD-797,000USD-338,000USD-42,000USD-84,000USD-445,000USD
    Free Cash Flow-276,886,000USD-232,830,000USD-185,068,000USD-94,635,000USD-54,919,000USD-29,821,000USD-36,140,000USD-27,289,000USD
    Investments-37,068,000USD-228,651,000USD-105,144,000USD-114,329,000USD-74,033,000USD-50,481,000USD28,310,000USD-29,462,000USD
    Total Cashflows From Investing Activities-37,563,000USD-228,651,000USD-94,252,000USD-115,126,000USD-74,292,000USD-50,481,000USD28,226,000USD-29,907,000USD
    Net Borrowings28,875,000USD0USD15,000,000USD4,554,000USD5,000,000USD-8,567,000USD-2,333,000USD-2,333,000USD
    Total Cash From Financing Activities426,742,000USD457,737,000USD225,670,000USD322,244,000USD125,275,000USD101,311,000USD70,000USD41,916,000USD
    Sale Purchase Of Stock1,119,000USD—580,000USD183,000USD125,275,000USD-44,000USD—-2,955,000USD
    Issuance Of Capital Stock352,197,000USD478,661,000USD25,086,000USD335,874,000USD131,202,000USD116,101,000USD2,283,000USD44,529,000USD
    Change In Cash112,788,000USD-3,233,000USD-52,752,000USD113,280,000USD-3,598,000USD21,051,000USD-7,760,000USD-14,835,000USD
    Begin Period Cash Flow99,594,000USD102,827,000USD155,579,000USD42,299,000USD45,897,000USD24,846,000USD32,606,000USD47,441,000USD
    End Period Cash Flow212,382,000USD99,594,000USD102,827,000USD155,579,000USD42,299,000USD45,897,000USD24,846,000USD32,606,000USD
    Other Cashflows From Financing Activities49,541,000USD4,077,000USD85,601,000USD25,370,000USD11,033,000USD84,774,000USD-77,000USD-2,613,000USD
    Unclassified Financing Cash Flow347,207,000USD-25,001,000USD138,975,000USD292,137,000USD-16,033,000USD25,192,000USD—49,817,000USD
    Change To Account Receivables—102,000USD—349,000USD-451,000USD99,000USD-84,000USD1,432,000USD
    Other Cashflows From Investing Activities—-228,651,000USD—-114,329,000USD79,000USD-3,000USD28,310,000USD-29,462,000USD
    Unclassified Investing Cash Flow—229,162,000USD11,790,000USD114,329,000USD——-28,310,000USD29,462,000USD
    Dividends Paid——-14,486,000USD——-44,000USD——
    Change To Inventory———-349,000USD451,000USD——-57,795,000USD
    Change To Liabilities———19,240,000USD3,035,000USD-426,000USD525,000USD-335,000USD
    Cash And Cash Equivalents Changes———113,280,000USD-3,598,000USD21,051,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductCollaboration100,000USD0001590750-26-000012
    Q1 2026Quarterly · 2026-03-31ProductLicense6,000USD0001590750-26-000012
    Q1 2026Quarterly · 2026-03-31ProductOther35,000USD0001590750-26-000012
    FY 2025Yearly · 2025-12-31ProductCollaboration800,000USD0001590750-26-000007
    FY 2025Yearly · 2025-12-31ProductLicense70,000,000USD0001590750-26-000007
    Q3 2025Quarterly · 2025-09-30ProductCollaboration600,000USD0001590750-25-000020
    Q3 2025Quarterly · 2025-09-30ProductLicense70,000,000USD0001590750-25-000020
    FY 2024Yearly · 2024-12-31ProductCollaboration300,000USD0001590750-26-000007
    FY 2024Yearly · 2024-12-31ProductLicense0USD0001590750-26-000007
    FY 2024Yearly · 2024-12-31ProductOther2,000USD0001590750-26-000007
    FY 2023Yearly · 2023-12-31ProductCollaboration300,000USD0001590750-26-000007
    FY 2023Yearly · 2023-12-31ProductLicense0USD0001590750-26-000007
    FY 2023Yearly · 2023-12-31ProductOther14,000USD0001590750-26-000007
    FY 2021Yearly · 2021-12-31ProductCollaboration Revenue2,963,000USD0001590750-22-000004
    FY 2021Yearly · 2021-12-31ProductGrant0USD0001590750-22-000004
    Q3 2021Quarterly · 2021-09-30ProductCollaboration Revenue208,000USD0001590750-21-000075
    Q3 2021Quarterly · 2021-09-30ProductGrant0USD0001590750-21-000075
    Q2 2021Quarterly · 2021-06-30ProductCollaboration Revenue0USD0001590750-21-000070
    Q2 2021Quarterly · 2021-06-30ProductCollaboration Revenue Related Party1,090,000USD0001590750-21-000070
    Q2 2021Quarterly · 2021-06-30ProductGrant0USD0001590750-21-000070
    Q1 2021Quarterly · 2021-03-31ProductCollaboration Revenue0USD0001590750-21-000065
    Q1 2021Quarterly · 2021-03-31ProductCollaboration Revenue Related Party1,451,000USD0001590750-21-000065
    Q1 2021Quarterly · 2021-03-31ProductGrant0USD0001590750-21-000065
    FY 2020Yearly · 2020-12-31ProductCollaboration Revenue735,000USD0001590750-22-000004
    FY 2020Yearly · 2020-12-31ProductGrant315,000USD0001590750-22-000004
    Q2 2020Quarterly · 2020-06-30ProductCollaboration Revenue0USD0001590750-21-000070
    Q2 2020Quarterly · 2020-06-30ProductCollaboration Revenue Related Party0USD0001590750-21-000070
    Q2 2020Quarterly · 2020-06-30ProductGrant168,000USD0001590750-21-000070
    Q1 2020Quarterly · 2020-03-31ProductCollaboration Revenue681,000USD0001590750-21-000065
    Q1 2020Quarterly · 2020-03-31ProductCollaboration Revenue Related Party0USD0001590750-21-000065
    Q1 2020Quarterly · 2020-03-31ProductGrant147,000USD0001590750-21-000065
    FY 2018Yearly · 2018-12-31ProductCollaboration Revenue — Milestone Payments3,690,000USD0001590750-19-000013
    FY 2018Yearly · 2018-12-31ProductGrant1,013,000USD0001590750-19-000013
    FY 2018Yearly · 2018-12-31ProductLicense0USD0001590750-19-000013
    FY 2018Yearly · 2018-12-31ProductReimbursement Revenue3,683,000USD0001590750-19-000013
    Q3 2018Quarterly · 2018-09-30ProductCollaboration Revenue814,000USD0001590750-18-000027
    Q3 2018Quarterly · 2018-09-30ProductGrant130,000USD0001590750-18-000027
    Q3 2018Quarterly · 2018-09-30ProductMilestone Payments0USD0001590750-18-000027

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.